SI1140148T1 - Stabilna formulacija raztopine glukagonu podobnega peptida-1 - Google Patents

Stabilna formulacija raztopine glukagonu podobnega peptida-1

Info

Publication number
SI1140148T1
SI1140148T1 SI9930857T SI9930857T SI1140148T1 SI 1140148 T1 SI1140148 T1 SI 1140148T1 SI 9930857 T SI9930857 T SI 9930857T SI 9930857 T SI9930857 T SI 9930857T SI 1140148 T1 SI1140148 T1 SI 1140148T1
Authority
SI
Slovenia
Prior art keywords
glucagon
shelf
peptide
solution formulation
stable solution
Prior art date
Application number
SI9930857T
Other languages
English (en)
Inventor
Mark L Brader
Allen H Pekar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from EP99967463A external-priority patent/EP1140148B1/en
Publication of SI1140148T1 publication Critical patent/SI1140148T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
SI9930857T 1998-12-22 1999-12-21 Stabilna formulacija raztopine glukagonu podobnega peptida-1 SI1140148T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11349998P 1998-12-22 1998-12-22
EP99967463A EP1140148B1 (en) 1998-12-22 1999-12-21 Shelf-stable solution formulation of glucagon-like peptide-1
PCT/US1999/030395 WO2000037098A1 (en) 1998-12-22 1999-12-21 Shelf-stable formulation of glucagon-like peptide-1

Publications (1)

Publication Number Publication Date
SI1140148T1 true SI1140148T1 (sl) 2006-04-30

Family

ID=35140603

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930857T SI1140148T1 (sl) 1998-12-22 1999-12-21 Stabilna formulacija raztopine glukagonu podobnega peptida-1

Country Status (2)

Country Link
EP (1) EP1600162A1 (sl)
SI (1) SI1140148T1 (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8920782B2 (en) 2005-01-14 2014-12-30 Camurus Ab Topical bioadhesive formulations
DE602005026998D1 (de) 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
AU2005325510B2 (en) 2005-01-21 2009-07-02 Camurus Ab Pharmaceutical lipid compositions
CA2609810C (en) 2005-06-06 2012-05-22 Camurus Ab Glp-1 analogue formulations
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
JP6374380B2 (ja) 2012-05-25 2018-08-15 カムルス エービー ソマトスタチン受容体作動薬製剤
CN103405753B (zh) * 2013-08-13 2016-05-11 上海仁会生物制药股份有限公司 稳定的促胰岛素分泌肽水针药物组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118666A (en) 1986-05-05 1992-06-02 The General Hospital Corporation Insulinotropic hormone
WO1987006941A1 (en) * 1986-05-05 1987-11-19 The General Hospital Corporation Insulinotropic hormone
EP0512042B1 (en) 1990-01-24 1998-04-08 BUCKLEY, Douglas I. Glp-1 analogs useful for diabetes treatment
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
GB9409496D0 (en) * 1994-05-12 1994-06-29 London Health Ass Method for improving glycaemic control in diabetes
US5512549A (en) 1994-10-18 1996-04-30 Eli Lilly And Company Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
ATE234625T1 (de) * 1994-12-23 2003-04-15 Novo Nordisk As Glp-1 zusammensetzungen mit verlängerter wirkdauer

Also Published As

Publication number Publication date
EP1600162A1 (en) 2005-11-30

Similar Documents

Publication Publication Date Title
IL136377A0 (en) Glucagon-like peptide-1 crystals
HUP9900604A3 (en) New peptide compounds that are analogues of the glucagon-like p
EP1049486A4 (en) GLP-1 FORMULATIONS
AU6479101A (en) Glucagon-like peptide-1 analogs
HUP9903714A3 (en) Glp-1 derivatives
HK1026627A1 (en) Novel exendin agonist compounds
HU9603082D0 (en) Neurokinine (tachykinine) antagonists
EP1017770A4 (en) AQUEOUS RINSE AID
AU6586298A (en) Glucagon-like peptide-1 analogs
SG82642A1 (en) Short circuit welder
HUP0001684A3 (en) Use of fumaric acid derivatives
HK1026211A1 (en) Substituted benzamides
HU9800555D0 (en) Substituted amino-compounds and their use as analgetic agent
EP0965321A4 (en) COMPOSITION FOR EXTERNAL USE
EP0915066A4 (en) DIELECTRIC CERAMIC COMPOSITION AND RESONATOR THEREOF
SI1140148T1 (sl) Stabilna formulacija raztopine glukagonu podobnega peptida-1
EP1067925A4 (en) ANTIDIABETIC CONNECTIONS
PL347208A1 (en) An improved process for the preparation of new antidiabetic agents
AU3047299A (en) Methods of delivering glp-1
ZA200304047B (en) Analogues of GLP-1.
TW335707U (en) Improved structure of flipper
HUP0004312A3 (en) Line-shape joint
AU2003202533A1 (en) Analogues of GLP-1
HU1000133D0 (en) Glp-1 derivatives
GB9810681D0 (en) Hormone